Avista Capital Partners Patents – Key Insights and Stats

Avista Capital Partners has a total of 6 patents globally, out of which 2 have been granted. The United States of America is where Avista Capital Partners has filed the maximum number of patents, followed by Germany and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Avista Capital Partners.

Avista Capital Partners was founded in 2005. Avista Capital Partners operates as a holding company. The Company offers private equity investment services through its subsidiaries. Avista Capital Holdings provides services to the global energy, healthcare, communication, and media industries.

Do read about some of the most popular patents of Avista Capital Partners which have been covered by us in this article and also you can find Avista Capital Partners patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Avista Capital Partners patent portfolio.

How many patents do the Founder and CEO of Avista Capital Partners have?

The Founder David Burgstahler (Also CEO), Thompson Dean have 0 patents.

How many patents does Avista Capital Partners have?

Avista Capital Partners has a total of 6 patents globally. These patents belong to 5 unique patent families. Out of 6 patents, no patents are active.

How Many Patents did Avista Capital Partners File Every Year?

Avista Capital Partners Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAvista Capital Partners Applications FiledAvista Capital Partners Patents Granted
20131
20091
20062
20051
20042
20031

How many Avista Capital Partners patents are Alive/Dead?

All the Avista Capital Partners patents are dead.

How Many Patents did Avista Capital Partners File in Different Countries?

Avista Capital Partners Worldwide Patent Filing

Countries in which Avista Capital Partners Filed Patents

CountryPatent
United States Of America3
Germany2
Europe1

Where are Research Centers of Avista Capital Partners Patents Located?

R&D Centres of Avista Capital Partners

List of Avista Capital Partners patents

Avista Capital Partners PatentTitle
US20060201440A1Ventilated Animal Tote With Protected Filters And Method Of Manufacturing Thereof
US20060205077A1Targeted Transgenesis Using The Rosa26 Locus
US20060201439A1Animal Tote With Compartmented Divider System
EP1583837A1Targeted Transgenesis Using The Rosa26 Locus
DE602005041212T2Targeted Transgenesis Of Short Hairpin Rna Expression Cassettes Using Recombinase-Mediated Cassette Exchange
DE60325494D1Sirna-Driven Gene Expression Suppression In Transgenetic Animals

What are Avista Capital Partners key innovation segments?

What Technologies are Covered by Avista Capital Partners?

The chart below distributes patents filed by Avista Capital Partners in different countries on the basis of the technology protected in patents. It also represents the markets where Avista Capital Partners thinks it’s important to protect particular technology inventions.

R&D Focus: How has Avista Capital Partners‘s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Avista Capital Partners?

Related Articles

Monetago Patents – Insights and Stats (Updated 2024)

Monetago has a total of 10 patents globally, out of which none have been granted. Of these 10 patents, all the patents are inactive. The United States of America is where Monetago has filed all their patents. Parallelly, United States of America seems to be the main focused R&D centre

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.